KMX vs LENZ · P/E 19, rev $25.88B vs rev $7.4M
CarMax Inc (KMX) versus LENZ Therapeutics Inc (LENZ) — a side-by-side from cached financials, not a winner call.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
KMX currently screens at market cap $10.26B and trailing P/E 18.9. LENZ currently screens at market cap $223.6M.
Not investment advice. Open the KMX and LENZ stock pages for the full models.
Not investment advice.